These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33891606)

  • 1. Association between in-stent neointimal characteristics and native coronary artery disease progression.
    Jung HW; Lim C; Bae HJ; Lee JH; Lee YJ; Kim JS; Lee SJ; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
    PLoS One; 2021; 16(4):e0247359. PubMed ID: 33891606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation.
    Kim JS; Lee JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):788-95. PubMed ID: 25051946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between pre-procedural plaque morphology and patterns of in-stent neointimal hyperplasia at 1-year follow-up in patients treated with new-generation drug-eluting stents: An optical coherence tomography based analysis.
    Shi SY; Chen KL; Gu J; Xu C; Chen QR; Chen YQ; Xu T; Ke HY; Sun JH; Ye F
    J Interv Cardiol; 2018 Dec; 31(6):737-746. PubMed ID: 30251273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo assessment of neointimal characteristics after drug-eluting stent implantation: Optical coherence tomography and histopathology validation study.
    Imanaka T; Fujii K; Hao H; Shibuya M; Saita T; Kawakami R; Fukunaga M; Kawai K; Tamaru H; Miki K; Horimatsu T; Sumiyoshi A; Nishimura M; Hirota S; Masuyama T; Ishihara M
    Int J Cardiol; 2016 Oct; 221():1043-7. PubMed ID: 27447812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
    Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable effect of optimal lipid-lowering therapy on neointimal tissue characteristics after drug-eluting stent implantation: qualitative optical coherence tomographic analysis.
    Jang JY; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Atherosclerosis; 2015 Oct; 242(2):553-9. PubMed ID: 26318104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optical coherence tomography study of neointimal morphology and strut coverage at different time intervals from implantation of biodegradable polymer-coated sirolimus-eluting stents.
    Legutko J; Gil RJ; Buszman PE; Kaluza GL; Mintz GS; Roleder T; Krol M; Wojdyla R; Pawlowski T; Brzezinski M; Kondys M; Skwarna B; Jakala J; Zasada W; Partyka L; Dudek D
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):302-309. PubMed ID: 29027737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomographic observation of morphological features of neointimal tissue after drug-eluting stent implantation.
    Lee SY; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2014 Jul; 55(4):944-52. PubMed ID: 24954322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neointima characteristics as a prognostic marker for drug-coated balloon angioplasty in patients with in-stent restenosis: an optical coherence tomography study.
    Kim HO; Jung HW; Lee JH; Kim JS; Hong SJ; Ahn CM; Kim BK; Kim W; Kim SJ; Kim W; Ko YG; Choi D; Hong MK; Jang Y
    Coron Artery Dis; 2020 Dec; 31(8):694-702. PubMed ID: 32976245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin receptor blockers on neointimal characteristics in angina patients requiring stent implantation: optical coherence tomography analysis.
    Cho JY; Hong SJ; Lim DS
    BMC Cardiovasc Disord; 2017 Nov; 17(1):278. PubMed ID: 29141596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-stent neointimal characteristics and late neointimal response after drug-eluting stent implantation: A preliminary observation.
    Fukuhara K; Okura H; Kume T; Yamada R; Neishi Y; Uemura S
    J Cardiol; 2016 May; 67(5):437-41. PubMed ID: 26276105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neointimal characteristics comparison between biodegradable-polymer and durable-polymer drug-eluting stents: 3-month follow-up optical coherence tomography light property analysis from the RESTORE registry.
    Kobayashi T; Sotomi Y; Suzuki S; Hamanaka Y; Nakatani S; Dijkstra J; Onuma Y; Serruys PW; Sakata Y; Hirayama A; Higuchi Y
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):205-215. PubMed ID: 31673850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, clinical presentation, and predictors of early neoatherosclerosis after drug-eluting stent implantation.
    Kim C; Kim BK; Lee SY; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Am Heart J; 2015 Sep; 170(3):591-7. PubMed ID: 26385044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenesis in Native Coronary Segments and In-Stent Neoatherogenesis Beyond Three Years After First-Generation Drug-Eluting Stent Implantation: Angiographic and Optical Coherence Tomography Study.
    Ochijewicz D; Tomaniak M; Barus P; Kołtowski Ł; Rdzanek A; Pietrasik A; Opolski G; Kochman J
    J Invasive Cardiol; 2021 Sep; 33(9):E738-E747. PubMed ID: 34433696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
    [No Abstract]   [Full Text] [Related]  

  • 18. Dynamic neointimal pattern after drug-eluting stent implantation defined by optical coherence tomography.
    Yamamoto E; Xing L; Higuma T; Minami Y; Bryniarski K; Zanchin T; Wang Z; Aguirre AD; Lee H; Jang IK
    Coron Artery Dis; 2017 Nov; 28(7):557-563. PubMed ID: 28704243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neointimal coverage and extra-stent lumen between sirolimus and everolimus-eluting stent using optical coherence tomography.
    Oda T; Okamura T; Yamada J; Miyagi N; Uehara H; Nao T; Tateishi H; Maeda T; Nakamura T; Shiraishi K; Nakashima T; Nishimura S; Miura T; Matsuzaki M; Yano M
    Heart Vessels; 2016 Apr; 31(4):449-56. PubMed ID: 25614415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of post-stent irregular protrusion and subsequent neointimal characteristics between second- and third-generation drug-eluting stent implantation.
    Miura T; Sonoda S; Sanuki Y; Naka Y; Okabe H; Setoyama K; Inoue K; Shimizu A; Anai R; Tsuda Y; Araki M; Otsuji Y
    J Cardiol; 2020 Nov; 76(5):464-471. PubMed ID: 32636130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.